Cle De Peau Beaute Correcting Veil | Ensulizole, Octinoxate, And Titanium Dioxide Cream while Breastfeeding
It is recommended to breastfeed exclusively for six months and then while introducing to other food sources extend it to twelve months. In this duration most mothers will need help of some sort of medication, It could be for short term like could and flue or it could be something chronic like Arthritis or Diabetes and here comes the question of safety of medication in use. In this post we will figure out what is Cle De Peau Beaute Correcting Veil | Ensulizole, Octinoxate, And Titanium Dioxide Cream and whether its safe to use Cle De Peau Beaute Correcting Veil | Ensulizole, Octinoxate, And Titanium Dioxide Cream while nursing or not.

What is Cle De Peau Beaute Correcting Veil | Ensulizole, Octinoxate, And Titanium Dioxide Cream ?


helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun

Purpose: Active ingredients Purpose ENSULIZOLE 1.0% Sunscreen OCTINOXATE 2.9% Sunscreen TITANIUM DIOXIDE 2.4% Sunscreen

Can I use Cle De Peau Beaute Correcting Veil | Ensulizole, Octinoxate, And Titanium Dioxide Cream while breastfeeding?

Cle De Peau Beaute Correcting Veil | Ensulizole, Octinoxate, And Titanium Dioxide Cream Contains 3 active ingredients that are Ensulizole, Octinoxate, Titanium dioxide. We do have breastfeeding analysis and safety rating of some of the active ingredients but unfortunately we do not have any information of some of active ingredients used. Below we have provided whatever information we do have. But please do not take any decision based on below provided information and contact your health care provider as this information is incomplete.

Octinoxate and Breastfeeding

Unsafe

Octinoxate (Octylmethoxycinnamate) has been detected in human urine, blood and breast milk and is known for moderate risk of skin allergy. Some studies suggest that Octinoxate has estrogen like effects however less than 1% skin penetration has been found in human laboratory studies. As not much study has been done on effects of Octinoxate during breast feeding its recommended to use safe alternatives.

Octyl Methoxycinnamate (OMC) is a frequently used UV-filter in sunscreens and other cosmetics. Octinoxate can be systemically absorbed after skin application, being found in the deeper layers of the stratum corneum as well as urine, plasma, and breast milk. The mean maximum plasma concentration detected after application of 2mg/cm2 sunscreen was 7ng/mL in women and 16ng/mL in men. FDA study found blood levels 13 times above cutoff for systemic exposure.

Several studies indicated that OMC acts as an endocrine disruptor due to the ability to interfere with endocrine system at different levels. In humans OMC exposure has minor, but statistically significant effects on the levels of testosterone and estradiol. Moreover, some studies suggested that OMC can interact with the hypothalamo-pituitary-thyroid (HPT) axis.

Moreover, a study of offspring of dams treated with OMC (5001000 mg/kg/day) showed sex-dependent behavioral changes, namely decreased motor activity in females, but not in males, and improved spatial learning in males, suggesting that OMC can affect neuronal development, however the doses used in these experiments were extremely high, not relevant to possible human exposure.

Note: Study and data for tropical use only

Warning: High dosage shall be avoided as reproductive system, thyroid and behavioral alterations in animal studies has been found, Tropical usage in breast area shall be avoided to prevent the OCTINOXATE passing orally in Infants.

Titanium dioxide and Breastfeeding

Low Risk

Not much study has been done on effects of topical usage of Titanium Dioxide during breast feeding but as there is no finding of Titanium Dioxide passing in breast milk its unlikely to cause any health issue for infant.

Some animal studies suggest that maternal exposure to titanium dioxide nanoparticles during pregnancy and lactation alters offspring hippocampal mRNA BAX and Bcl-2 levels, induces apoptosis and decreases neurogenesis. But dosage was significantly higher than daily possible exposure to humans.

Note: Study and data for tropical use only. Inhalation concerns in powder or spray products.

Warning: Tropical usage in breast area shall be avoided to prevent the Titanium Dioxide passing orally in Infants. Titanium dioxide is possibly carcinogenic to humans. Titanium dioxide can be drastically more harmful if used as powder or spray as risk of inhalation can increase significantly.


What if I already have used Cle De Peau Beaute Correcting Veil | Ensulizole, Octinoxate, And Titanium Dioxide Cream?

Not much study has been done on safety of Cle De Peau Beaute Correcting Veil | Ensulizole, Octinoxate, And Titanium Dioxide Cream in breastfeeding and its ingredients. Even we do not have complete information about usage of Cle De Peau Beaute Correcting Veil | Ensulizole, Octinoxate, And Titanium Dioxide Cream in breastfeeding so at this point a trained medical professional could be your best bet. If you observe anything abnormal with your baby please contact 911.


My doctor has prescribed me Cle De Peau Beaute Correcting Veil | Ensulizole, Octinoxate, And Titanium Dioxide Cream, what should I do?

If your doctor considers Cle De Peau Beaute Correcting Veil | Ensulizole, Octinoxate, And Titanium Dioxide Cream safe enough to prescribe for you that means its benefits should outweigh its known risks for you.


If I am using Cle De Peau Beaute Correcting Veil | Ensulizole, Octinoxate, And Titanium Dioxide Cream, will my baby need extra monitoring?

We are not Sure, Please check with your healthcare provider or doctor.


Who can I talk to if I have questions about usage of Cle De Peau Beaute Correcting Veil | Ensulizole, Octinoxate, And Titanium Dioxide Cream in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week